ArticleHealth psychology : official journal of the Division of Health Psychology, American Psychological Association2022
Race, trust, and COVID-19 vaccine hesitancy in people with opioid use disorder.
Article in Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 14 citations in OpenAlex.
- Designing and evaluating a technology-based intervention to address deep ambivalence about COVID vaccination among people who inject drugs.Health education research · 2025Trial
- Exploring the Role of Vaccine Confidence in COVID-19 Vaccination Among a Community-Based Sample of Women Who Use Drugs in Baltimore, Maryland.Journal of health care for the poor and underserved · 2025Article
- Vaccine Equity: Lessons Learned Exploring Facilitators and Barriers to COVID-19 Vaccination in Urban Black Communities.Journal of racial and ethnic health disparities · 2024Article
- COVID-19 vaccine acceptance in the general population and under-resourced communities from high-income countries: realist review.BMJ open · 2024Review
- Predictors of COVID-19 vaccine uptake among people who use substances: a case study in Tehran.Substance abuse treatment, prevention, and policy · 2024Article
- Article
- COVID-19 Vaccine Hesitancy Among Medicare Beneficiaries with and Without Cancer History: A US Population-based Study.Journal of community health · 2023Article
- Opiate maintenance patients' attitudes and self-reported adherence to protective measures against SARS-CoV-2 infections.Frontiers in psychiatry · 2023Article
- Article
- Possible predictors of Covid-19 vaccine hesitancy in the psychiatric population - A scoping review.Psychiatry research communications · 2022Article
- COVID-19 vaccination coverage and vaccine hesitancy among people with opioid use disorder in Barcelona, Spain.Drug and alcohol review · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
Abstract
objectiveVaccination against coronavirus disease 2019 (COVID-19) is a promising avenue for arresting the COVID-19 pandemic, yet suboptimal rates of vaccine uptake in at-risk groups may hinder efficacy and worsen existing health disparities. People with opioid use disorder (OUD) are likely to face increased vulnerability to COVID-19 due to a confluence of biological and social risk factors. We sought to assess factors associated with willingness to vaccinate against COVID-19 in people with OUD.
methodPhone surveys were conducted from May to October 2020 with participants enrolled in an urban methadone maintenance program (MMP). Participants were adults who met
resultsWe surveyed 109 people with OUD enrolled in a MMP (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.